App Dealroom

Published September 15, 2026 · Updated September 16, 2026

Ori Biotech signs 10-year, $120M deal to automate commercial cell therapy manufacturing

Read the full story at App Dealroom

Definium Therapeutics notches third straight Phase 3 win as DT120 psychedelic hits goals in generalised anxiety disorder · Zealand Pharma out.